AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

G A Donzella; Dominique Schols; Steven Lin; José A. Esté; Kirsten Nagashima; Paul J. Maddon; Graham P. Allaway; Thomas P. Sakmar; Geoffrey Henson; De Clercq Erik; John P. Moore

doi:10.1038/nm0198-072

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Mutations at the CXCR4 interaction sites for AMD3100 influence anti‐CXCR4 antibody binding and HIV‐1 entry

Sigrid Hatse, Katrien Princen, Kurt Vermeire, Lars‐Ole Gerlach, Mette M. Rosenkilde, Thue W. Schwartz, Gary Bridger, De Clercq Erik, Dominique Schols

Article2003

The anti-HIV activity of the CXCR4 inhibitor AMD3100 is independent of the CXCR4/HIV coreceptor level

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols

Article2005

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Sigrid Hatse, Katrien Princen, De Clercq Erik, Mette M. Rosenkilde, Thue W. Schwartz, Pedro E. Hernandez-Abad, Renato T. Skerlj, Gary Bridger, Dominique Schols

Article2012

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

Wenwen Chen, Peng Zhan, De Clercq Erik, Xinyong Liu

Article2009

CXCR4 Chemokine Receptor Antagonists from Ultra-rigid Metal Complexes Profoundly Inhibit HIV-1 Replication, and also AMD3100-resistant Strains

Stephen J. Archibald, Dirk Daelemans, Timothy J. Hubin, Dana Huskens, Dominique Schols, Kristel Van Laethem, De Clercq Erik, Christophe Pannecouque